{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:35:18Z","timestamp":1785368118928,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10741-020-10066-6","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T11:04:29Z","timestamp":1609931069000},"page":"961-971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6786-3498","authenticated-orcid":false,"given":"Artemio","family":"Garc\u00eda-Escobar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Jim\u00e9nez-Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Galeote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Jurado-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"10066_CR1","doi-asserted-by":"publisher","unstructured":"Zhu N, Zhang D, Wenling W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Gao GF, Tan W et al (2019) A Novel Coronavirus from patients with Pneumonia in China, N Engl J Med 382(8):727\u2013733. https:\/\/doi.org\/10.1056\/NEJMoa2001017. https:\/\/pubmed.ncbi.nlm.nih.gov\/31978945\/","DOI":"10.1056\/NEJMoa2001017"},{"key":"10066_CR2","doi-asserted-by":"crossref","unstructured":"Gorbalenya AE, Baker SC, Baric RS, Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D, Perlman S, Poon LLM, Samborskiy DV, Sidorov IA, Sola I, Ziebuhr J\u00a0et al (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCov and naming it SARS-CoV-2. Nat Microbiol 5, 536\u2013544\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/32123347\/","DOI":"10.1038\/s41564-020-0695-z"},{"key":"10066_CR3","doi-asserted-by":"publisher","unstructured":"Lu G, Liu D (2020) SARS-like\u00a0Virus in\u00a0the\u00a0Middle\u00a0East: A\u00a0Truly\u00a0Bat-Related\u00a0Coronavirus\u00a0Causing\u00a0Human\u00a0Diseases.\u00a0Protein\u00a0Cell 3(11):803\u20135.\u00a0https:\/\/doi.org\/10.1007\/s13238-012-2811-1https:\/\/pubmed.ncbi.nlm.nih.gov\/23143870\/","DOI":"10.1007\/s13238-012-2811-1"},{"key":"10066_CR4","unstructured":"World Health Organization. Rolling updates on coronavirus disease (COVID-19). 2020 (https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/events-as-they-happen)."},{"key":"10066_CR5","unstructured":"https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/therapeutic-options.html"},{"key":"10066_CR6","doi-asserted-by":"crossref","unstructured":"Colson P, Rolain JM, Raoult D\u00a0et al (2020) Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents 105923.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/32070753\/","DOI":"10.1016\/j.ijantimicag.2020.105923"},{"key":"10066_CR7","doi-asserted-by":"publisher","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D\u00a0et al (2020) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis ciaaa237.\u00a0https:\/\/doi.org\/10.1093\/cid\/ciaa237. https:\/\/pubmed.ncbi.nlm.nih.gov\/32150618\/","DOI":"10.1093\/cid\/ciaa237"},{"key":"10066_CR8","doi-asserted-by":"crossref","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honore S, Colson P, Chabriere E, Scola B, Rolain J, Brouqui P, Raoult D\u00a0et al (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 105949.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/32205204\/","DOI":"10.1101\/2020.03.16.20037135"},{"key":"10066_CR9","doi-asserted-by":"publisher","unstructured":"Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, Weinberg P, Kirkwood J, Muse A, DeHovitz J, Blog DS, Hutton B, Holtgrave DR, Zucker HA et al (2020) Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA 11:e208630.\u00a0https:\/\/doi.org\/10.1001\/jama.2020.8630. https:\/\/pubmed.ncbi.nlm.nih.gov\/32392282\/","DOI":"10.1001\/jama.2020.8630"},{"key":"10066_CR10","doi-asserted-by":"publisher","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCOV) in vitro. Cell Res (3):269\u2013271. https:\/\/doi.org\/10.1038\/s41422-020-0282-0. https:\/\/pubmed.ncbi.nlm.nih.gov\/32020029\/","DOI":"10.1038\/s41422-020-0282-0"},{"key":"10066_CR11","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhang D, Du Guanhua, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C\u00a0et al (2020) Remdesivir in Adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(20)31022-9","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"10066_CR12","doi-asserted-by":"crossref","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C\u00a0et al (2020) A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 382(19):1787\u20131799. https:\/\/pubmed.ncbi.nlm.nih.gov\/32187464\/","DOI":"10.1056\/NEJMoa2001282"},{"key":"10066_CR13","doi-asserted-by":"publisher","unstructured":"Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Dongjing L, Zhang Z, Liu Y, Liu L\u00a0et al (2020) Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 323(16):1582\u20131589. https:\/\/doi.org\/10.1001\/jama.2020.4783. https:\/\/pubmed.ncbi.nlm.nih.gov\/32219428\/","DOI":"10.1001\/jama.2020.4783"},{"key":"10066_CR14","doi-asserted-by":"publisher","unstructured":"Zeng Q, Yu Z, Gou J, Li G, Ma S, Zhang G, Xu J, Lin W, Cui G, Zhang M, Li C, Wang Z, Zhang Z, Liu Z\u00a0et al (2020) Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients. J Infect Dis jiaa228. https:\/\/doi.org\/10.1093\/infdis\/jiaa228. https:\/\/pubmed.ncbi.nlm.nih.gov\/32348485\/","DOI":"10.1093\/infdis\/jiaa228"},{"key":"10066_CR15","doi-asserted-by":"publisher","unstructured":"Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen K, Wang Q, Zhou H, Yan J, Qi J\u00a0et al (2020) Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181(4):894\u2013904.e9. https:\/\/doi.org\/10.1016\/j.cell.2020.03.045. https:\/\/pubmed.ncbi.nlm.nih.gov\/32275855\/","DOI":"10.1016\/j.cell.2020.03.045"},{"key":"10066_CR16","doi-asserted-by":"publisher","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB et al (2020) Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA.\u00a0https:\/\/doi.org\/10.1001\/jama.2020.6019https:\/\/pubmed.ncbi.nlm.nih.gov\/32282022\/","DOI":"10.1001\/jama.2020.6019"},{"key":"10066_CR17","doi-asserted-by":"publisher","unstructured":"Krammer F (2020) SARS-CoV-2 vaccines in development. Nature 586(7830):516\u2013527.\u00a0https:\/\/doi.org\/10.1038\/s41586-020-2798-3. https:\/\/pubmed.ncbi.nlm.nih.gov\/32967006\/","DOI":"10.1038\/s41586-020-2798-3"},{"key":"10066_CR18","doi-asserted-by":"publisher","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y\u00a0et al (2020) Risk factors associated with acude respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994. https:\/\/pubmed.ncbi.nlm.nih.gov\/32167524\/","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"10066_CR19","doi-asserted-by":"crossref","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si H, Zhu Y, Li B, Huang C, Chen H, Chen J, Luo Y, Guo H, Jiang R, Liu M, Chen Y, Shen X, Wang X, Zheng X, Zhao K, Chen Q, Deng F, Liu L, Yan B, Zhan F, Wang Y, Xiao G, Shi Z\u00a0et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/pubmed.ncbi.nlm.nih.gov\/32015507\/","DOI":"10.1038\/s41586-020-2012-7"},{"key":"10066_CR20","doi-asserted-by":"publisher","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE\u00a0(2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111(20):2605\u201310.\u00a0https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.510461. https:\/\/pubmed.ncbi.nlm.nih.gov\/15897343\/","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"10066_CR21","doi-asserted-by":"publisher","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM (2004) Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43(5):970\u20136. https:\/\/doi.org\/10.1161\/01.HYP.0000124667.34652.1a. https:\/\/pubmed.ncbi.nlm.nih.gov\/15007027\/","DOI":"10.1161\/01.HYP.0000124667.34652.1a"},{"key":"10066_CR22","doi-asserted-by":"publisher","unstructured":"Fang LK, Karakiulakis G, Roth M\u00a0et al (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID19 infection? Lancet Respir Med (4):e21.\u00a0https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/32171062\/","DOI":"10.1016\/S2213-2600(20)30116-8"},{"key":"10066_CR23","doi-asserted-by":"publisher","unstructured":"Bavishi C, Maddox TM, Messerli FH et al (2020) Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1282. https:\/\/pubmed.ncbi.nlm.nih.gov\/32242890\/","DOI":"10.1001\/jamacardio.2020.1282"},{"key":"10066_CR24","doi-asserted-by":"publisher","unstructured":"Mancia\u00a0G, Rea F,\u00a0Ludergnani\u00a0M, Apolone G, Corrao G\u00a0et al (2020) Renin-angiotensin-aldosterone\u00a0system\u00a0blockers\u00a0and\u00a0the\u00a0risk\u00a0of\u00a0Covid-19. N Engl J\u00a0Med NEJMoa2006923.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2006923. https:\/\/pubmed.ncbi.nlm.nih.gov\/32356627\/","DOI":"10.1056\/NEJMoa2006923"},{"key":"10066_CR25","doi-asserted-by":"publisher","unstructured":"Reynolds HR,\u00a0Adhikari\u00a0S,\u00a0Pulgarin\u00a0C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS et al (2020) Renin-angiotensin-aldosterone\u00a0system\u00a0inhibitors\u00a0and\u00a0risk\u00a0of\u00a0Covid-19. N Engl J\u00a0Med NEJMoa2008975.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2008975. https:\/\/pubmed.ncbi.nlm.nih.gov\/32356628\/","DOI":"10.1056\/NEJMoa2008975"},{"key":"10066_CR26","doi-asserted-by":"crossref","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ\u00a0et al (2000) A human homolog of angiotensin-converting enzyme: Cloning and function- al expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238\u201343 https:\/\/pubmed.ncbi.nlm.nih.gov\/10924499\/","DOI":"10.1074\/jbc.M002615200"},{"key":"10066_CR27","doi-asserted-by":"crossref","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart E, Acton S\u00a0et al (2000) A novel angiotensin-convert- ing enzyme-related carboxypeptidase (ACE2) converts angiotensin I to an- giotensin 1\u20139. Circ Res 87:E1-E9. https:\/\/pubmed.ncbi.nlm.nih.gov\/10969042\/","DOI":"10.1161\/01.RES.87.5.e1"},{"key":"10066_CR28","doi-asserted-by":"crossref","unstructured":"Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, Ryan D, Fisher M, Williams D, Dales N.A, Patane MA, Pantoliano MW\u00a0et al (2004) ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279(17);17996\u20138007. https:\/\/pubmed.ncbi.nlm.nih.gov\/14754895\/","DOI":"10.1074\/jbc.M311191200"},{"key":"10066_CR29","doi-asserted-by":"crossref","unstructured":"Iwata M, Silva Enciso JE, Greenberg BH\u00a0et al (2009) Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme. Am J Physiol Cell Physiol 297(5):C1318\u201329. https:\/\/pubmed.ncbi.nlm.nih.gov\/19759332\/","DOI":"10.1152\/ajpcell.00036.2009"},{"key":"10066_CR30","doi-asserted-by":"crossref","unstructured":"Jia HP, Look DC, Tan P, Shi L, Hickey M, Gakhar L, Chappell MC et al (2009) Wohlford-Lenane C, McCray Jr P.B. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 297(1):L84\u201396. https:\/\/pubmed.ncbi.nlm.nih.gov\/19411314\/","DOI":"10.1152\/ajplung.00071.2009"},{"key":"10066_CR31","doi-asserted-by":"publisher","unstructured":"Lambert DW, Clarke NE, Hooper NM, Turner AJ\u00a0et al (2008) Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Lett 582(2):385\u201390.\u00a0https:\/\/doi.org\/10.1016\/j.febslet.2007.11.085. Epub 2007 Dec 10. https:\/\/pubmed.ncbi.nlm.nih.gov\/18070603\/","DOI":"10.1016\/j.febslet.2007.11.085"},{"key":"10066_CR32","doi-asserted-by":"crossref","unstructured":"Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P\u00a0et al (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277(17):14838 43. https:\/\/pubmed.ncbi.nlm.nih.gov\/11815627\/","DOI":"10.1074\/jbc.M200581200"},{"key":"10066_CR33","doi-asserted-by":"crossref","unstructured":"Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V, Hanada T, Hanada R, Lipinski S, Wild B, Camargo SMR, Singer D, Richter A, Kuba K, Fukamizu A, Schreiber S, Clevers H, Verrey F, Rosenstiel P, Penninger JM\u00a0et al (2012) ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487(7408):477\u201381. https:\/\/pubmed.ncbi.nlm.nih.gov\/22837003\/","DOI":"10.1038\/nature11228"},{"key":"10066_CR34","doi-asserted-by":"crossref","unstructured":"Qian Z, Travanty EA, Oko L, Edeen K, Berglund A, Wang J, Ito Y, Holmes KV, Mason RJ et al (2013) Innate Immune Response of Human Alveolar Type II Cells Infected with Severe Acute Respiratory Syndrome\u2013Coronavirus. Am J Respir Cell Mol Biol 48(6):742\u2013748. https:\/\/pubmed.ncbi.nlm.nih.gov\/23418343\/","DOI":"10.1165\/rcmb.2012-0339OC"},{"key":"10066_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/978-0-387-33012-9_85","volume":"581","author":"HP Jia","year":"2006","unstructured":"Jia HP, Look DC, Hichey M et al (2006) Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization. Adv Exp Med Biol 581:479\u2013484","journal-title":"Adv Exp Med Biol"},{"key":"10066_CR36","doi-asserted-by":"crossref","unstructured":"Fraga-Silva RA, Sorg B, Wankhede M, Dedeugd C, Jun JY, Baker MB, Li Y, Castellano RK, Katovich MJ, Raizada MK, Ferreira AJ et al (2010) ACE2 Activation promotes antithrombotic activity. Mol Med 16(5\u20136):210\u2013215. https:\/\/pubmed.ncbi.nlm.nih.gov\/20111697\/","DOI":"10.2119\/molmed.2009.00160"},{"key":"10066_CR37","doi-asserted-by":"publisher","unstructured":"Senchenkova EY, Russell J, Almeida-Paula LD, Harding JW, Granger DN et al (2010) Angiotensin II-mediated microvascular thrombosis. Hypertension 56(6):1089\u201395. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.158220. https:\/\/pubmed.ncbi.nlm.nih.gov\/20975035\/","DOI":"10.1161\/HYPERTENSIONAHA.110.158220"},{"key":"10066_CR38","doi-asserted-by":"publisher","unstructured":"Fraga-Silva RA, Pinheiro SV, Goncalves AC, Alenina N, Bader M, Santos RA et al (2008) The antithrombotic effect of angiotensin-(1\u20137) involves mas-mediated NO release from platelets. Mol Med 14(1\u20132):28\u201335.\u00a0https:\/\/doi.org\/10.2119\/2007-00073. https:\/\/pubmed.ncbi.nlm.nih.gov\/18026570\/","DOI":"10.2119\/2007-00073"},{"key":"10066_CR39","doi-asserted-by":"publisher","unstructured":"Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM et al (2007) Angiotensin-(1\u20137) through receptor mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49(1):185\u201392.\u00a0https:\/\/doi.org\/10.1161\/01.HYP.0000251865.35728.2f. https:\/\/pubmed.ncbi.nlm.nih.gov\/17116756\/","DOI":"10.1161\/01.HYP.0000251865.35728.2f"},{"key":"10066_CR40","doi-asserted-by":"crossref","unstructured":"Epelman S, Tang WH, Chen SY, Lente FV, Francis GS, Sen S et al (2008) Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol 52(9):750\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/18718423\/","DOI":"10.1016\/j.jacc.2008.02.088"},{"key":"10066_CR41","doi-asserted-by":"crossref","unstructured":"Epelman S, Shrestha K, Troughton RW, Francis GS, Sen S, Klein AL, Tang WHW et al (2009) Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes. J Card Fail 15(7):565\u201371. https:\/\/pubmed.ncbi.nlm.nih.gov\/19700132\/","DOI":"10.1016\/j.cardfail.2009.01.014"},{"key":"10066_CR42","doi-asserted-by":"crossref","unstructured":"Ramchand J, Patel SK, Kearney LG, Matalanis G, Farouque O, Srivastava PM, Burrell LM et al (2020) Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis. JACC Cardiovasc Imaging 13(3):655\u2013664. https:\/\/pubmed.ncbi.nlm.nih.gov\/31607667\/","DOI":"10.1016\/j.jcmg.2019.09.005"},{"key":"10066_CR43","doi-asserted-by":"crossref","unstructured":"Shao Z, Schuster A, Borowski AG, Thakur A, Li L, Tang WHW et al (2019) Soluble angiotensin converting enzyme 2 levels in chronic heart failure is associated with decreased exercise capacity and increased oxidative stress-mediated endotelial dysfunction. Transl Res 212:8088. https:\/\/pubmed.ncbi.nlm.nih.gov\/31323221\/","DOI":"10.1016\/j.trsl.2019.06.004"},{"key":"10066_CR44","doi-asserted-by":"crossref","unstructured":"Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L, Sandholm N, Thormas MC, Groop P et al (2012) Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens 30(2):375\u201383. https:\/\/pubmed.ncbi.nlm.nih.gov\/22179088\/","DOI":"10.1097\/HJH.0b013e32834f04b6"},{"key":"10066_CR45","doi-asserted-by":"crossref","unstructured":"Ortiz-P\u00e9rez JT, Riera M, Bosch X, Caralt TM, Perea RJ, Pascual J, Soler MJ et al (2013) Role of circulating angiotensin coverting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. PLoS One 22;8(4):e61695. https:\/\/pubmed.ncbi.nlm.nih.gov\/23630610\/","DOI":"10.1371\/journal.pone.0061695"},{"key":"10066_CR46","doi-asserted-by":"crossref","unstructured":"Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM et al (2018) Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS One 13(6):e0198144. https:\/\/pubmed.ncbi.nlm.nih.gov\/29897923\/","DOI":"10.1371\/journal.pone.0198144"},{"key":"10066_CR47","doi-asserted-by":"crossref","unstructured":"Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM et al (2017) Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace 19(8):1280\u20131287. https:\/\/pubmed.ncbi.nlm.nih.gov\/27738071\/","DOI":"10.1093\/europace\/euw246"},{"key":"10066_CR48","doi-asserted-by":"crossref","unstructured":"Haschke M, Schuster M, Poglitsch M, Loibner H, Salzberg M, Bruggisser M, Penninger J, Krahenbuhl S et al (2013) Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin Pharmacokinet 52(9):783\u201392. https:\/\/pubmed.ncbi.nlm.nih.gov\/23681967\/","DOI":"10.1007\/s40262-013-0072-7"},{"key":"10066_CR49","doi-asserted-by":"crossref","unstructured":"Basu R, Poglitsch M, Yogasundaram H, Thomas J, Rowe BH et al (2017) Oudit G.Y. Roles of angiotensin peptides and recombinant human ACE2 in heart failure. J Am Coll Cardiol 69(7):805\u2013819. https:\/\/pubmed.ncbi.nlm.nih.gov\/28209222\/","DOI":"10.1016\/j.jacc.2016.11.064"},{"key":"10066_CR50","doi-asserted-by":"crossref","unstructured":"Khan A, Beenthin C, Zeno B, Albertson TE, Boyd J, Christie JD, Hall R, Poirier G, Ronco JJ, Tidswell M, Hardes K, Powley WM, Wright TJ, Siederer SK, Fairman DA, Lipson DA, Bayliffe AI, Lazaar AL et al (2017) A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care 21(1):234. https:\/\/pubmed.ncbi.nlm.nih.gov\/28877748\/","DOI":"10.1186\/s13054-017-1823-x"},{"key":"10066_CR51","doi-asserted-by":"crossref","unstructured":"Patel VB, Zhong JC, Grant MB, Oudit GY et al (2016) Role of the ACE2\/Angio 1\u20137 axis of the Renin-Angiotensin System in Heart Failure. Circ Res 118(8):1313\u201326. https:\/\/pubmed.ncbi.nlm.nih.gov\/27081112\/","DOI":"10.1161\/CIRCRESAHA.116.307708"},{"key":"10066_CR52","doi-asserted-by":"crossref","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/14647384\/","DOI":"10.1038\/nature02145"},{"key":"10066_CR53","doi-asserted-by":"crossref","unstructured":"Li F, Li W, Farzan M, Harrison SC et al (2005) Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864\u20131868. https:\/\/pubmed.ncbi.nlm.nih.gov\/16166518\/","DOI":"10.1126\/science.1116480"},{"key":"10066_CR54","doi-asserted-by":"publisher","unstructured":"Monteil V, Kwon H, Prado P, Hagelkruys A, Wimmer RA, Stahl M, Leopoldi A, Garreta E, Del Pozo CH, Prosper F, Romero JP, Wirnsberger G, Zhang H, Slutsky AS, Conder R, Montserrat N, Mirazimi A, Penninger JM et al (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181(4):905\u2013913.e7.\u00a0https:\/\/doi.org\/10.1016\/j.cell.2020.04.004. https:\/\/pubmed.ncbi.nlm.nih.gov\/32333836\/","DOI":"10.1016\/j.cell.2020.04.004"},{"key":"10066_CR55","doi-asserted-by":"publisher","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A et al (2020) COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 323(16):1574\u20131581. https:\/\/doi.org\/10.1001\/jama.2020.5394. https:\/\/pubmed.ncbi.nlm.nih.gov\/32250385\/","DOI":"10.1001\/jama.2020.5394"},{"key":"10066_CR56","doi-asserted-by":"publisher","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F et al (2020) Eur J Intern Med S0953\u20136205(20)30151\u20135.\u00a0https:\/\/doi.org\/10.1016\/j.ejim.2020.04.037. https:\/\/pubmed.ncbi.nlm.nih.gov\/32336612\/","DOI":"10.1016\/j.ejim.2020.04.037"},{"issue":"1","key":"10066_CR57","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","volume":"11","author":"C Lei","year":"2020","unstructured":"Lei C, Qian K, Li T, Zhang S, Fu W, Ding M, Hu S et al (2020) Neutralization of SARS-CoV-2 Spike Pseudotyped Virus by Recombinant ACE2-Ig. Nat Commun 11(1):2070. https:\/\/doi.org\/10.1038\/s41467-020-16048-4","journal-title":"Nat Commun"},{"key":"10066_CR58","doi-asserted-by":"publisher","unstructured":"Lamas GA (2015) Cardiology Patient Page. Chelation Therapy: A new look at an old treatment for heart disease, particularly in diabetics. Circulation 131(21):e505\u20136.\u00a0\u00a0https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010774. https:\/\/pubmed.ncbi.nlm.nih.gov\/26015468\/","DOI":"10.1161\/CIRCULATIONAHA.114.010774"},{"key":"10066_CR59","doi-asserted-by":"publisher","unstructured":"Escolar E, Lamas GA, Mark DB, Boineau R, Goertz C, Rosenberg Y, Nahin RL, Ouyang P, Rozema T, Magaziner A, Nahas R, Lewis EF, Lindblad L, Lee KL et al (2014) The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the trial to assess chelation therapy (TACT). Circ Cardiovasc Qual Outcomes (1):15\u201324.\u00a0https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.113.000663. https:\/\/pubmed.ncbi.nlm.nih.gov\/24254885\/","DOI":"10.1161\/CIRCOUTCOMES.113.000663"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-10066-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T19:23:09Z","timestamp":1670700189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-10066-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10066"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-10066-6","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"8 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}